Scinai Immunotherapeutics Ltd. Quarterly Liabilities, Current in USD from Q4 2021 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: Scinai Immunotherapeutics Ltd. quarterly Liabilities, Current history and growth rate from Q4 2021 to Q2 2024.
Scinai Immunotherapeutics Ltd. Liabilities, Current for the quarter ending June 30, 2024 was $1.67M, a 11.4% decline year-over-year.

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2024	$1.67M	-$216K	-11.4%	Jun 30, 2024	6-K	2024-09-09
Q4 2023	$1.78M	-$558K	-23.9%	Dec 31, 2023	6-K	2024-09-09
Q2 2023	$1.89M			Jun 30, 2023	6-K/A	2023-08-18
Q1 2023	$2.58M			Mar 31, 2023	10-Q	2023-05-15
Q4 2022	$2.34M	-$106K	-4.34%	Dec 31, 2022	20-F	2024-05-15
Q4 2021	$2.44M			Dec 31, 2021	10-K	2023-04-17

* An asterisk sign (*) next to the value indicates that the value is likely invalid.